Published in
Elsevier, European Journal of Cancer, (109), p. 21-27, 2019
DOI: 10.1016/j.ejca.2018.10.014
Links
Tools
Immune-related adverse events predict the therapeutic efficacy of anti–PD-1 antibodies in cancer patients
Journal article published in 2019 by
J. Rogado,
J. M. Sánchez-Torres,
N. Romero-Laorden 
,
A. I. Ballesteros,
V. Pacheco-Barcia,
A. Ramos-Leví,
R. Arranz,
A. Lorenzo,
P. Gullón,
O. Donnay,
M. Adrados,
P. Costas,
J. Aspa,
A. Alfranca,
R. Mondéjar
and other authors.
,
A. I. Ballesteros,
V. Pacheco-Barcia,
A. Ramos-Leví,
R. Arranz,
A. Lorenzo,
P. Gullón,
O. Donnay,
M. Adrados,
P. Costas,
J. Aspa,
A. Alfranca,
R. Mondéjar
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 